RxDoctor Payments Data

Nitin Patel, MD

Psychiatry · Valdosta, GANPI 1770511156

Payments from drug & device makers

$2,897in general payments, 2019–2025

Across 147 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$468
  • Axsome Therapeutics, Inc.$376
  • Vanda Pharmaceuticals Inc.$320
  • Otsuka America Pharmaceutical, Inc.$248
  • Takeda Pharmaceuticals U.S.A., Inc.$219
  • Ironshore Pharmaceuticals Inc.$185
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,897 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$39,872
Medicare patients
86
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl22$29,152
TrintellixVortioxetine Hydrobromide24$11,513
BelsomraSuvorexant14$6,140
LexaproEscitalopram Oxalate13$5,220
Fluoxetine Hcl37$4,326
Duloxetine Hcl259$3,813
Aripiprazole205$3,518
Venlafaxine Hcl ErVenlafaxine Hcl232$2,740
Desvenlafaxine Succinate ErDesvenlafaxine Succinate47$2,670
Ziprasidone Hcl34$2,148
Buspirone Hcl139$2,047
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$1,901
Bupropion XlBupropion Hcl199$1,867
Alprazolam274$1,472
Paroxetine ErParoxetine Hcl11$1,312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Lexapro$468$34,37135 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$219$11,51324 claims
Almatica Pharma LLCSertraline Hcl$83$1,254242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →